Ipsen (IPSEY) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,71%	1 092,80	−7,77	−0,71%	—	1 100,57	1 098,94	1 103,80	1 084,24	—	—
SIXC Communications SIXC Communications	SIXC −0,07%	604,74	−0,41	−0,07%	—	605,15	605,15	606,69	602,76	—	—
SIXE Energy SIXE Energy	SIXE +1,64%	1 214,80	+19,61	+1,64%	—	1 195,19	1 204,71	1 221,69	1 204,71	—	—
SIXI Industrials SIXI Industrials	SIXI −0,88%	1 724,57	−15,34	−0,88%	—	1 739,91	1 734,50	1 734,50	1 710,67	—	—
SIXM Financials SIXM Financials	SIXM +0,14%	639,43	+0,87	+0,14%	—	638,56	640,21	645,32	638,69	—	—
SIXR Staples SIXR Staples	SIXR +0,91%	839,15	+7,58	+0,91%	—	831,57	840,48	844,16	834,54	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +1,06%	215,62	+2,26	+1,06%	—	213,36	213,36	215,79	212,77	—	—
SIXT Technology SIXT Technology	SIXT −1,69%	3 179,52	−54,66	−1,69%	—	3 234,18	3 171,86	3 195,36	3 145,46	—	—
SIXU Utilities SIXU Utilities	SIXU +0,13%	936,91	+1,26	+0,13%	—	935,65	937,31	941,44	933,16	—	—
SIXV Health care SIXV Health care	SIXV +0,24%	1 452,77	+3,51	+0,24%	—	1 449,26	1 454,77	1 462,65	1 447,95	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,72%	2 365,18	−17,27	−0,72%	—	2 382,45	2 371,19	2 380,45	2 362,86	—	—

IPSEY:OTCMKTS

Ipsen

47,95 USD

0,00%

(0,00) 1 D

28. apr., 16:00:00 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for IPSEY …

Åpne

47,95 USD

Høy

47,95 USD

Lav

47,95 USD

Markedsverdi

13,80 mrd.

Snittvolum

657,00

Volum

454,00

52 u høy

49,15 USD

52 u lav

26,25 USD

Beta

0,47

Utestående aksjer

335,26 mill.

Antall ansatte

Relaterte aksjer

Daiichi Sankyo Co Ltd - ADR

16,40 USD

+1,05%

ALPMY

Astellas Pharma ADR Representing 1 Ord Shs

14,41 USD

−4,57%

Nyhetssaker

Fra kilder på nettet

CNBC

for 33 minutter siden

S&P 500 futures edge higher as Wall Street looks ahead to ‘Mag 7’ earnings and Fed decision

Stock Titan

for 46 minutter siden

Agios (NASDAQ: AGIO) doubles mitapivat revenue and funds 2026 pipeline catalysts

Simply Wall Street

for 46 minutter siden

At US$601, Is IES Holdings, Inc. (NASDAQ:IESC) Worth Looking At Closely?

Stock Titan

for 53 minutter siden

GE HealthCare (Nasdaq: GEHC) posts Q1 2026 results and lowers profit outlook

Profil

Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia

Om Ipsen

Administrerende direktørDavid Loew

Ansatte5,54k

Grunnlagt1929

Hovedkontor-

Sektor-

Nettstedipsen.com

Alle verdier i EUR	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	968,55 mill.	968,55 mill.	996,05 mill.	996,05 mill.
Varekostnad	162,55 mill.	162,55 mill.	212,90 mill.	212,90 mill.
Direkte driftskostnader	162,55 mill.	162,55 mill.	212,90 mill.	212,90 mill.
Utgifter til forskning og utvikling	182,45 mill.	182,45 mill.	194,55 mill.	194,55 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	303,50 mill.	303,50 mill.	278,60 mill.	278,60 mill.
Driftskostnader	552,50 mill.	552,50 mill.	523,20 mill.	523,20 mill.
Totale driftskostnader	715,05 mill.	715,05 mill.	736,10 mill.	736,10 mill.
Driftsinntekter	253,50 mill.	253,50 mill.	259,95 mill.	259,95 mill.
Andre ikke-operasjonelle inntekter	−12,05 mill.	−12,05 mill.	−7,35 mill.	−7,35 mill.
EBT inkludert uvanlige elementer	212,50 mill.	212,50 mill.	76,55 mill.	76,55 mill.
EBT uten uvanlige elementer	246,25 mill.	246,25 mill.	248,45 mill.	248,45 mill.
Kostnad for inntektsskatt	44,75 mill.	44,75 mill.	22,05 mill.	22,05 mill.
Faktisk avgiftssats	21,06 %	21,06 %	28,80 %	28,80 %
Andre driftskostnader	66,55 mill.	66,55 mill.	50,05 mill.	50,05 mill.
Nettoinntekt	167,00 mill.	167,00 mill.	54,75 mill.	54,75 mill.
Netto fortjenestemargin	17,24 %	17,24 %	5,50 %	5,50 %
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	5,75 mill.	5,75 mill.	8,25 mill.	8,25 mill.
Rentekostnader	−7,85 mill.	−7,85 mill.	−10,20 mill.	−10,20 mill.
Netto rentekostnader	−2,10 mill.	−2,10 mill.	−1,95 mill.	−1,95 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	338,80 mill.	338,80 mill.	331,25 mill.	331,25 mill.
Gevinst eller tap ved salg av eiendeler	−300,00k	−300,00k	9,75 mill.	9,75 mill.

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning